<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<xbrli:xbrl xmlns:xbrli="http://www.xbrl.org/2003/instance"
            xmlns="http://www.w3.org/1999/xhtml"
            xmlns:b="http://xbrl.dcca.dk/entryBalanceSheetAccountFormIncomeStatementByNature"
            xmlns:c="http://xbrl.dcca.dk/fsa"
            xmlns:d="http://xbrl.dcca.dk/cmn"
            xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26"
            xmlns:e="http://xbrl.dcca.dk/gsd"
            xmlns:f="http://xbrl.dcca.dk/sob"
            xmlns:g="http://xbrl.dcca.dk/arr"
            xmlns:h="http://xbrl.dcca.dk/mrv"
            xmlns:link="http://www.xbrl.org/2003/linkbase"
            xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
            xmlns:ix="http://www.xbrl.org/2013/inlineXBRL"
            xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
            xmlns:xlink="http://www.w3.org/1999/xlink">
   <link:schemaRef xlink:href="http://archprod.service.eogs.dk/taxonomy/20251001/entryDanishGAAPBalanceSheetAccountFormIncomeStatementByNatureIncludingManagementsReviewStatisticsAndTax20251001.xsd"
                   xlink:type="simple"/>
   <xbrli:context id="c187">
						<xbrli:entity>
							  <xbrli:identifier scheme="http://www.dcca.dk/cvr">42924911</xbrli:identifier>
						</xbrli:entity>
						<xbrli:period>
							  <xbrli:startDate>2025-01-01</xbrli:startDate>
							  <xbrli:endDate>2025-12-31</xbrli:endDate>
						</xbrli:period>
						<xbrli:scenario>
							  <xbrldi:explicitMember dimension="c:ClassesOfEquityDimension">
								c:ContributedCapitalMember
							</xbrldi:explicitMember>
						</xbrli:scenario>
					</xbrli:context>
   <xbrli:context id="c40">
						<xbrli:entity>
							  <xbrli:identifier scheme="http://www.dcca.dk/cvr">42924911</xbrli:identifier>
						</xbrli:entity>
						<xbrli:period>
							  <xbrli:startDate>2025-01-01</xbrli:startDate>
							  <xbrli:endDate>2025-12-31</xbrli:endDate>
						</xbrli:period>
					</xbrli:context>
   <xbrli:context id="c826">
						<xbrli:entity>
							  <xbrli:identifier scheme="http://www.dcca.dk/cvr">42924911</xbrli:identifier>
						</xbrli:entity>
						<xbrli:period>
							  <xbrli:startDate>2025-01-01</xbrli:startDate>
							  <xbrli:endDate>2025-12-31</xbrli:endDate>
						</xbrli:period>
						<xbrli:scenario>
							  <xbrldi:typedMember dimension="d:IdentificationOfMemberOfExecutiveBoardDimension">
								    <d:memberOfBoardIdentifier>
									1
								</d:memberOfBoardIdentifier>
							  </xbrldi:typedMember>
						</xbrli:scenario>
					</xbrli:context>
   <xbrli:context id="c827">
						<xbrli:entity>
							  <xbrli:identifier scheme="http://www.dcca.dk/cvr">42924911</xbrli:identifier>
						</xbrli:entity>
						<xbrli:period>
							  <xbrli:startDate>2025-01-01</xbrli:startDate>
							  <xbrli:endDate>2025-12-31</xbrli:endDate>
						</xbrli:period>
						<xbrli:scenario>
							  <xbrldi:typedMember dimension="d:IdentificationOfMemberOfExecutiveBoardDimension">
								    <d:memberOfBoardIdentifier>
									2
								</d:memberOfBoardIdentifier>
							  </xbrldi:typedMember>
						</xbrli:scenario>
					</xbrli:context>
   <xbrli:context id="c321">
						<xbrli:entity>
							  <xbrli:identifier scheme="http://www.dcca.dk/cvr">42924911</xbrli:identifier>
						</xbrli:entity>
						<xbrli:period>
							  <xbrli:startDate>2025-01-01</xbrli:startDate>
							  <xbrli:endDate>2025-12-31</xbrli:endDate>
						</xbrli:period>
						<xbrli:scenario>
							  <xbrldi:typedMember dimension="d:IdentificationOfAuditorDimension">
								    <d:auditorIdentifier>
									1
								</d:auditorIdentifier>
							  </xbrldi:typedMember>
						</xbrli:scenario>
					</xbrli:context>
   <xbrli:context id="c182">
						<xbrli:entity>
							  <xbrli:identifier scheme="http://www.dcca.dk/cvr">42924911</xbrli:identifier>
						</xbrli:entity>
						<xbrli:period>
							  <xbrli:startDate>2024-01-01</xbrli:startDate>
							  <xbrli:endDate>2024-12-31</xbrli:endDate>
						</xbrli:period>
					</xbrli:context>
   <xbrli:context id="c178">
						<xbrli:entity>
							  <xbrli:identifier scheme="http://www.dcca.dk/cvr">42924911</xbrli:identifier>
						</xbrli:entity>
						<xbrli:period>
							  <xbrli:instant>2025-12-31</xbrli:instant>
						</xbrli:period>
					</xbrli:context>
   <xbrli:context id="c179">
						<xbrli:entity>
							  <xbrli:identifier scheme="http://www.dcca.dk/cvr">42924911</xbrli:identifier>
						</xbrli:entity>
						<xbrli:period>
							  <xbrli:instant>2024-12-31</xbrli:instant>
						</xbrli:period>
					</xbrli:context>
   <xbrli:context id="c188">
						<xbrli:entity>
							  <xbrli:identifier scheme="http://www.dcca.dk/cvr">42924911</xbrli:identifier>
						</xbrli:entity>
						<xbrli:period>
							  <xbrli:instant>2025-01-01</xbrli:instant>
						</xbrli:period>
						<xbrli:scenario>
							  <xbrldi:explicitMember dimension="c:ClassesOfEquityDimension">
								c:ContributedCapitalMember
							</xbrldi:explicitMember>
						</xbrli:scenario>
					</xbrli:context>
   <xbrli:context id="c209">
						<xbrli:entity>
							  <xbrli:identifier scheme="http://www.dcca.dk/cvr">42924911</xbrli:identifier>
						</xbrli:entity>
						<xbrli:period>
							  <xbrli:instant>2025-01-01</xbrli:instant>
						</xbrli:period>
						<xbrli:scenario>
							  <xbrldi:explicitMember dimension="c:ClassesOfEquityDimension">
								c:RetainedEarningsMember
							</xbrldi:explicitMember>
						</xbrli:scenario>
					</xbrli:context>
   <xbrli:context id="c208">
						<xbrli:entity>
							  <xbrli:identifier scheme="http://www.dcca.dk/cvr">42924911</xbrli:identifier>
						</xbrli:entity>
						<xbrli:period>
							  <xbrli:startDate>2025-01-01</xbrli:startDate>
							  <xbrli:endDate>2025-12-31</xbrli:endDate>
						</xbrli:period>
						<xbrli:scenario>
							  <xbrldi:explicitMember dimension="c:ClassesOfEquityDimension">
								c:RetainedEarningsMember
							</xbrldi:explicitMember>
						</xbrli:scenario>
					</xbrli:context>
   <xbrli:context id="c189">
						<xbrli:entity>
							  <xbrli:identifier scheme="http://www.dcca.dk/cvr">42924911</xbrli:identifier>
						</xbrli:entity>
						<xbrli:period>
							  <xbrli:instant>2025-12-31</xbrli:instant>
						</xbrli:period>
						<xbrli:scenario>
							  <xbrldi:explicitMember dimension="c:ClassesOfEquityDimension">
								c:ContributedCapitalMember
							</xbrldi:explicitMember>
						</xbrli:scenario>
					</xbrli:context>
   <xbrli:context id="c210">
						<xbrli:entity>
							  <xbrli:identifier scheme="http://www.dcca.dk/cvr">42924911</xbrli:identifier>
						</xbrli:entity>
						<xbrli:period>
							  <xbrli:instant>2025-12-31</xbrli:instant>
						</xbrli:period>
						<xbrli:scenario>
							  <xbrldi:explicitMember dimension="c:ClassesOfEquityDimension">
								c:RetainedEarningsMember
							</xbrldi:explicitMember>
						</xbrli:scenario>
					</xbrli:context>
   <xbrli:context id="c324">
						<xbrli:entity>
							  <xbrli:identifier scheme="http://www.dcca.dk/cvr">42924911</xbrli:identifier>
						</xbrli:entity>
						<xbrli:period>
							  <xbrli:instant>2025-01-01</xbrli:instant>
						</xbrli:period>
						<xbrli:scenario>
							  <xbrldi:explicitMember dimension="c:ClassesOfIntangibleAssetsDimension">
								c:AcquiredIntangibleAssetsMember
							</xbrldi:explicitMember>
						</xbrli:scenario>
					</xbrli:context>
   <xbrli:context id="c348">
						<xbrli:entity>
							  <xbrli:identifier scheme="http://www.dcca.dk/cvr">42924911</xbrli:identifier>
						</xbrli:entity>
						<xbrli:period>
							  <xbrli:instant>2025-01-01</xbrli:instant>
						</xbrli:period>
						<xbrli:scenario>
							  <xbrldi:explicitMember dimension="c:ClassesOfIntangibleAssetsDimension">
								c:GoodwillMember
							</xbrldi:explicitMember>
						</xbrli:scenario>
					</xbrli:context>
   <xbrli:context id="c323">
						<xbrli:entity>
							  <xbrli:identifier scheme="http://www.dcca.dk/cvr">42924911</xbrli:identifier>
						</xbrli:entity>
						<xbrli:period>
							  <xbrli:startDate>2025-01-01</xbrli:startDate>
							  <xbrli:endDate>2025-12-31</xbrli:endDate>
						</xbrli:period>
						<xbrli:scenario>
							  <xbrldi:explicitMember dimension="c:ClassesOfIntangibleAssetsDimension">
								c:AcquiredIntangibleAssetsMember
							</xbrldi:explicitMember>
						</xbrli:scenario>
					</xbrli:context>
   <xbrli:context id="c347">
						<xbrli:entity>
							  <xbrli:identifier scheme="http://www.dcca.dk/cvr">42924911</xbrli:identifier>
						</xbrli:entity>
						<xbrli:period>
							  <xbrli:startDate>2025-01-01</xbrli:startDate>
							  <xbrli:endDate>2025-12-31</xbrli:endDate>
						</xbrli:period>
						<xbrli:scenario>
							  <xbrldi:explicitMember dimension="c:ClassesOfIntangibleAssetsDimension">
								c:GoodwillMember
							</xbrldi:explicitMember>
						</xbrli:scenario>
					</xbrli:context>
   <xbrli:context id="c326">
						<xbrli:entity>
							  <xbrli:identifier scheme="http://www.dcca.dk/cvr">42924911</xbrli:identifier>
						</xbrli:entity>
						<xbrli:period>
							  <xbrli:instant>2025-12-31</xbrli:instant>
						</xbrli:period>
						<xbrli:scenario>
							  <xbrldi:explicitMember dimension="c:ClassesOfIntangibleAssetsDimension">
								c:AcquiredIntangibleAssetsMember
							</xbrldi:explicitMember>
						</xbrli:scenario>
					</xbrli:context>
   <xbrli:context id="c350">
						<xbrli:entity>
							  <xbrli:identifier scheme="http://www.dcca.dk/cvr">42924911</xbrli:identifier>
						</xbrli:entity>
						<xbrli:period>
							  <xbrli:instant>2025-12-31</xbrli:instant>
						</xbrli:period>
						<xbrli:scenario>
							  <xbrldi:explicitMember dimension="c:ClassesOfIntangibleAssetsDimension">
								c:GoodwillMember
							</xbrldi:explicitMember>
						</xbrli:scenario>
					</xbrli:context>
   <xbrli:context id="c545">
						<xbrli:entity>
							  <xbrli:identifier scheme="http://www.dcca.dk/cvr">42924911</xbrli:identifier>
						</xbrli:entity>
						<xbrli:period>
							  <xbrli:instant>2025-01-01</xbrli:instant>
						</xbrli:period>
						<xbrli:scenario>
							  <xbrldi:explicitMember dimension="c:ClassesOfPropertyPlantAndEquipmentDimension">
								c:PlantAndMachineryMember
							</xbrldi:explicitMember>
						</xbrli:scenario>
					</xbrli:context>
   <xbrli:context id="c515">
						<xbrli:entity>
							  <xbrli:identifier scheme="http://www.dcca.dk/cvr">42924911</xbrli:identifier>
						</xbrli:entity>
						<xbrli:period>
							  <xbrli:instant>2025-01-01</xbrli:instant>
						</xbrli:period>
						<xbrli:scenario>
							  <xbrldi:explicitMember dimension="c:ClassesOfPropertyPlantAndEquipmentDimension">
								c:BiologicalAssetsMember
							</xbrldi:explicitMember>
						</xbrli:scenario>
					</xbrli:context>
   <xbrli:context id="c543">
						<xbrli:entity>
							  <xbrli:identifier scheme="http://www.dcca.dk/cvr">42924911</xbrli:identifier>
						</xbrli:entity>
						<xbrli:period>
							  <xbrli:startDate>2025-01-01</xbrli:startDate>
							  <xbrli:endDate>2025-12-31</xbrli:endDate>
						</xbrli:period>
						<xbrli:scenario>
							  <xbrldi:explicitMember dimension="c:ClassesOfPropertyPlantAndEquipmentDimension">
								c:PlantAndMachineryMember
							</xbrldi:explicitMember>
						</xbrli:scenario>
					</xbrli:context>
   <xbrli:context id="c513">
						<xbrli:entity>
							  <xbrli:identifier scheme="http://www.dcca.dk/cvr">42924911</xbrli:identifier>
						</xbrli:entity>
						<xbrli:period>
							  <xbrli:startDate>2025-01-01</xbrli:startDate>
							  <xbrli:endDate>2025-12-31</xbrli:endDate>
						</xbrli:period>
						<xbrli:scenario>
							  <xbrldi:explicitMember dimension="c:ClassesOfPropertyPlantAndEquipmentDimension">
								c:BiologicalAssetsMember
							</xbrldi:explicitMember>
						</xbrli:scenario>
					</xbrli:context>
   <xbrli:context id="c547">
						<xbrli:entity>
							  <xbrli:identifier scheme="http://www.dcca.dk/cvr">42924911</xbrli:identifier>
						</xbrli:entity>
						<xbrli:period>
							  <xbrli:instant>2025-12-31</xbrli:instant>
						</xbrli:period>
						<xbrli:scenario>
							  <xbrldi:explicitMember dimension="c:ClassesOfPropertyPlantAndEquipmentDimension">
								c:PlantAndMachineryMember
							</xbrldi:explicitMember>
						</xbrli:scenario>
					</xbrli:context>
   <xbrli:context id="c517">
						<xbrli:entity>
							  <xbrli:identifier scheme="http://www.dcca.dk/cvr">42924911</xbrli:identifier>
						</xbrli:entity>
						<xbrli:period>
							  <xbrli:instant>2025-12-31</xbrli:instant>
						</xbrli:period>
						<xbrli:scenario>
							  <xbrldi:explicitMember dimension="c:ClassesOfPropertyPlantAndEquipmentDimension">
								c:BiologicalAssetsMember
							</xbrldi:explicitMember>
						</xbrli:scenario>
					</xbrli:context>
   <xbrli:context id="c592">
						<xbrli:entity>
							  <xbrli:identifier scheme="http://www.dcca.dk/cvr">42924911</xbrli:identifier>
						</xbrli:entity>
						<xbrli:period>
							  <xbrli:instant>2025-01-01</xbrli:instant>
						</xbrli:period>
						<xbrli:scenario>
							  <xbrldi:explicitMember dimension="c:ClassesOfInvestmentsDimension">
								c:ParticipatingInterestsMember
							</xbrldi:explicitMember>
						</xbrli:scenario>
					</xbrli:context>
   <xbrli:context id="c602">
						<xbrli:entity>
							  <xbrli:identifier scheme="http://www.dcca.dk/cvr">42924911</xbrli:identifier>
						</xbrli:entity>
						<xbrli:period>
							  <xbrli:instant>2025-01-01</xbrli:instant>
						</xbrli:period>
						<xbrli:scenario>
							  <xbrldi:explicitMember dimension="c:ClassesOfInvestmentsDimension">
								c:DepositsLongtermInvestmentsAndReceivablesMember
							</xbrldi:explicitMember>
						</xbrli:scenario>
					</xbrli:context>
   <xbrli:context id="c594">
						<xbrli:entity>
							  <xbrli:identifier scheme="http://www.dcca.dk/cvr">42924911</xbrli:identifier>
						</xbrli:entity>
						<xbrli:period>
							  <xbrli:instant>2025-12-31</xbrli:instant>
						</xbrli:period>
						<xbrli:scenario>
							  <xbrldi:explicitMember dimension="c:ClassesOfInvestmentsDimension">
								c:ParticipatingInterestsMember
							</xbrldi:explicitMember>
						</xbrli:scenario>
					</xbrli:context>
   <xbrli:context id="c604">
						<xbrli:entity>
							  <xbrli:identifier scheme="http://www.dcca.dk/cvr">42924911</xbrli:identifier>
						</xbrli:entity>
						<xbrli:period>
							  <xbrli:instant>2025-12-31</xbrli:instant>
						</xbrli:period>
						<xbrli:scenario>
							  <xbrldi:explicitMember dimension="c:ClassesOfInvestmentsDimension">
								c:DepositsLongtermInvestmentsAndReceivablesMember
							</xbrldi:explicitMember>
						</xbrli:scenario>
					</xbrli:context>
   <xbrli:unit id="u1">
						<xbrli:measure>iso4217:DKK</xbrli:measure>
					</xbrli:unit>
   <xbrli:unit id="u0">
						<xbrli:measure>xbrli:pure</xbrli:measure>
					</xbrli:unit>
   <c:IncreaseDecreaseOfEquityThroughCorrectionsOfErrors contextRef="c187" decimals="0" unitRef="u1">0</c:IncreaseDecreaseOfEquityThroughCorrectionsOfErrors>
   <c:IncreaseDecreaseOfEquityThroughChangesInAccountingPolicies contextRef="c187" decimals="0" unitRef="u1">0</c:IncreaseDecreaseOfEquityThroughChangesInAccountingPolicies>
   <c:AccountingPoliciesAreUnchangedFromPreviousPeriod contextRef="c40">true</c:AccountingPoliciesAreUnchangedFromPreviousPeriod>
   <e:NameOfSubmittingEnterprise contextRef="c40"
                                 id="ParaIndex_6_CellNumber_NAVN_CellInstance_0"
                                 xml:lang="en">BDO Statsautoriseret Revisionspartnerselskab</e:NameOfSubmittingEnterprise>
   <e:AddressOfSubmittingEnterpriseStreetAndNumber contextRef="c40"
                                                   id="ParaIndex_7_CellNumber_GADE_CellInstance_0"
                                                   xml:lang="en">Roms Hule 4, 1. sal</e:AddressOfSubmittingEnterpriseStreetAndNumber>
   <e:AddressOfSubmittingEnterprisePostcodeAndTown contextRef="c40"
                                                   id="ParaIndex_8_CellNumber_BY_CellInstance_0"
                                                   xml:lang="en">DK-7100 Vejle</e:AddressOfSubmittingEnterprisePostcodeAndTown>
   <e:IdentificationNumberCvrOfSubmittingEnterprise contextRef="c40"
                                                    id="ParaIndex_9_CellNumber_CVR1_CellInstance_0"
                                                    xml:lang="en">45719375</e:IdentificationNumberCvrOfSubmittingEnterprise>
   <e:InformationOnTypeOfSubmittedReport contextRef="c40">Årsrapport</e:InformationOnTypeOfSubmittedReport>
   <e:DateOfGeneralMeeting contextRef="c40">2026-04-21</e:DateOfGeneralMeeting>
   <e:NameAndSurnameOfChairmanOfGeneralMeeting contextRef="c40"
                                               id="ParaIndex_186_CellNumber_A4.A5_CellInstance_0"
                                               xml:lang="en">Mikael Wædeled Sigvardsen</e:NameAndSurnameOfChairmanOfGeneralMeeting>
   <e:NameOfReportingEntity contextRef="c40"
                            id="ParaIndex_480_CellNumber_B1.B2_CellInstance_0"
                            xml:lang="en">Solvang Genetics ApS</e:NameOfReportingEntity>
   <e:AddressOfReportingEntityStreetName contextRef="c40"
                                         id="ParaIndex_481_CellNumber_B1.B3_CellInstance_0"
                                         xml:lang="en">c/o Ulrik Rønnenkamp Lundgaard</e:AddressOfReportingEntityStreetName>
   <e:AddressOfReportingEntityPostCodeIdentifier contextRef="c40"
                                                 id="ParaIndex_483_CellNumber_B1.B5_CellInstance_0"
                                                 xml:lang="en">4593 Eskebjerg</e:AddressOfReportingEntityPostCodeIdentifier>
   <d:TypeOfAuditorAssistance contextRef="c40"
                              id="ParaIndex_484_CellNumber_B1.C2_CellInstance_0"
                              xml:lang="en">Den uafhængige revisors erklæring</d:TypeOfAuditorAssistance>
   <e:IdentificationNumberCvrOfReportingEntity contextRef="c40"
                                               id="ParaIndex_565_CellNumber_B1.C12_CellInstance_0"
                                               xml:lang="en">42924911</e:IdentificationNumberCvrOfReportingEntity>
   <e:DateOfFoundationOfReportingEntity contextRef="c40">2021-12-22</e:DateOfFoundationOfReportingEntity>
   <e:RegisteredOfficeOfReportingEntity contextRef="c40"
                                        id="ParaIndex_609_CellNumber_B1.B16_CellInstance_0"
                                        xml:lang="en">Kalundborg</e:RegisteredOfficeOfReportingEntity>
   <e:ReportingPeriodStartDate contextRef="c40">2025-01-01</e:ReportingPeriodStartDate>
   <e:ReportingPeriodEndDate contextRef="c40">2025-12-31</e:ReportingPeriodEndDate>
   <e:PrecedingReportingPeriodStartDate contextRef="c40">2024-01-01</e:PrecedingReportingPeriodStartDate>
   <e:PredingReportingPeriodEndDate contextRef="c40">2024-12-31</e:PredingReportingPeriodEndDate>
   <d:NameOfAuditFirm contextRef="c40"
                      id="ParaIndex_1183_CellNumber_B5.B2_CellInstance_0"
                      xml:lang="en">BDO Statsautoriseret Revisionspartnerselskab</d:NameOfAuditFirm>
   <e:AddressOfAuditorStreetName contextRef="c40"
                                 id="ParaIndex_1184_CellNumber_B5.B3_CellInstance_0"
                                 xml:lang="en">Roms Hule</e:AddressOfAuditorStreetName>
   <e:AddressOfAuditorStreetBuildingIdentifier contextRef="c40"
                                               id="ParaIndex_1184_CellNumber_B5.C3_CellInstance_0"
                                               xml:lang="en">4, 1. sal</e:AddressOfAuditorStreetBuildingIdentifier>
   <e:AddressOfAuditorPostCodeIdentifier contextRef="c40"
                                         id="ParaIndex_1185_CellNumber_B5.B4_CellInstance_0"
                                         xml:lang="en">7100</e:AddressOfAuditorPostCodeIdentifier>
   <e:AddressOfAuditorDistrictName contextRef="c40"
                                   id="ParaIndex_1185_CellNumber_B5.C4_CellInstance_0"
                                   xml:lang="en">Vejle</e:AddressOfAuditorDistrictName>
   <f:IdentificationOfApprovedAnnualReport contextRef="c40"
                                           id="SectionStart_2149_SectionEnd_2166_SectionUID_1412757665_ParaIndex_2151">Today the Executive Board have discussed and approved the Annual Report of Solvang Genetics ApS for the fi­nan­ci­al year 1 January  - 31 December 2025.
												
											
												
											
												
											
												
											
												
											</f:IdentificationOfApprovedAnnualReport>
   <f:ConfirmationThatAnnualReportIsPresentedInAccordanceWithRequirementsProvidedForByLegislationAnyStandardsAndRequirementsProvidedByArticlesOfAssociationOrByAgreement contextRef="c40"
                                                                                                                                                                         id="SectionStart_2167_SectionEnd_2184_SectionUID_1412757694_ParaIndex_2169">The Annual Report is presented in accor­dance with the Da­nish Fi­nan­ci­al State­ments Act.
												
											
												
											
												
											
												
											
												
											</f:ConfirmationThatAnnualReportIsPresentedInAccordanceWithRequirementsProvidedForByLegislationAnyStandardsAndRequirementsProvidedByArticlesOfAssociationOrByAgreement>
   <f:ConfirmationThatFinancialStatementGivesTrueAndFairViewOfAssetsLiabilitiesEquityFinancialPositionAndResults contextRef="c40"
                                                                                                                 id="SectionStart_2185_SectionEnd_2202_SectionUID_1412757709_ParaIndex_2187">In our opinion the Fi­nan­ci­al Sta­te­ments give a true and fair view of the Company's assets, liabilities and financial position at 31 December 2025 and of the results of the Company's operations for the fi­nan­ci­al year 1 January  - 31 December 2025.
												
											
												
											
												
											
												
											
												
											
												
											</f:ConfirmationThatFinancialStatementGivesTrueAndFairViewOfAssetsLiabilitiesEquityFinancialPositionAndResults>
   <f:ManagementsStatementAboutManagementsReview contextRef="c40"
                                                 id="SectionStart_2203_SectionEnd_2220_SectionUID_1412757720_ParaIndex_2205">The Management Commentary includes in our opinion a fair presentation of the matters dealt with in the Commentary.
												
											
												
											
												
											
												
											
												
											
												
											
												
											</f:ManagementsStatementAboutManagementsReview>
   <f:RecommendationForApprovalOfAnnualReportByGeneralMeeting contextRef="c40"
                                                              id="SectionStart_2248_SectionEnd_2256_SectionUID_1412758043_ParaIndex_2250">We recommend the Annual Report be approved at the Annual General Meeting.
												
											
												
											
												
											</f:RecommendationForApprovalOfAnnualReportByGeneralMeeting>
   <f:PlaceOfSignatureOfStatement contextRef="c40"
                                  id="ParaIndex_2286_CellNumber_K6.BYV_CellInstance_0"
                                  xml:lang="en">Eskebjerg</f:PlaceOfSignatureOfStatement>
   <f:DateOfApprovalOfAnnualReport contextRef="c40">2026-04-21</f:DateOfApprovalOfAnnualReport>
   <d:NameAndSurnameOfMemberOfExecutiveBoard contextRef="c826"
                                             id="ParaIndex_2394_CellNumber_I5.A6_CellInstance_0"
                                             xml:lang="en">Mads Hans Kring</d:NameAndSurnameOfMemberOfExecutiveBoard>
   <d:NameAndSurnameOfMemberOfExecutiveBoard contextRef="c827"
                                             id="ParaIndex_2395_CellNumber_I5.B6_CellInstance_0"
                                             xml:lang="en">Mikael Wædeled Sigvardsen</d:NameAndSurnameOfMemberOfExecutiveBoard>
   <g:AddresseeOfAuditorsReportOnAuditedFinancialStatements contextRef="c40"
                                                            id="SectionStart_3030_SectionEnd_3038_SectionUID_1566918529_ParaIndex_3032">To the Shareholder of Solvang Genetics ApS
												
											
												
											</g:AddresseeOfAuditorsReportOnAuditedFinancialStatements>
   <g:TypeOfModifiedOpinionOnAuditedFinancialStatements contextRef="c40"
                                                        id="ParaIndex_3073_CellNumber_K3.E32_CellInstance_0"
                                                        xml:lang="en">Konklusion med forbehold</g:TypeOfModifiedOpinionOnAuditedFinancialStatements>
   <g:OpinionOnAuditedFinancialStatements contextRef="c40"
                                          id="SectionStart_3078_SectionEnd_3133_SectionUID_1566918530_ParaIndex_3080">We ha­ve au­di­ted the Fi­nan­ci­al Sta­te­ments of Solvang Genetics ApS for the fi­nan­ci­al year 1 January - 31 December 2025, which comprise income statement, Balance Sheet, sta­te­ment of chan­ges in e­qui­ty, no­tes and a summary of significant accounting policies. The Fi­nan­ci­al Sta­te­ments are pre­pared in accordance with the Da­nish Fi­nan­ci­al State­ments Act.
													
													 
												
											Ex­cept for the pos­sib­le ef­fects of the mat­ter des­cri­bed in the ''Ba­sis for Qua­li­fi­ed O­pi­ni­on'' pa­ra­graph, it is our o­pi­ni­on that the Fi­nan­ci­al Sta­te­ments give a true and fair view of the assets, liabilities and financial position of the Com­pa­ny at 31 December 2025 and of the results of the Com­pa­ny's operations for the fi­nan­ci­al year 1 January - 31 December 2025 in accordance with the Da­nish Fi­nan­ci­al State­ments Act.
													
													 
												
											
												
											</g:OpinionOnAuditedFinancialStatements>
   <g:DescriptionOfQualificationsOfAuditedFinancialStatements contextRef="c40"
                                                              id="SectionStart_3170_SectionEnd_3223_SectionUID_1566918534_ParaIndex_3172">Basis for Qualified OpinionGrundlag for konklusion med forbehold
												
											We were appointed as the company’s auditors during 2025 and were therefore unable to observe the counting of the company’s inventories at the beginning of the financial year.  We have not otherwise been able to obtain sufficient and appropriate audit evidence regarding the existence of the company’s inventories at the beginning of the financial year as of 31 December 2024. Since the opening inventories are included in the calculation of cost of goods sold, we were unable to determine whether adjustments might have been necessary to the year’s result. For this reason, we express a qualification regarding the possible impact of the above matter.
													
													 
												
											We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the “Auditor’s Responsibilities for the Audit of the Fi­nan­ci­al Sta­te­ments” section of our report. We are independent of the Com­pa­ny in accordance with the International Ethics Standards Board for Accountants’ International Code of Ethics for Professional Accountants (including International Independence Standards) (IESBA Code), together with the ethical requirements that are relevant to our audit of the Financial Statements in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements and the IESBA Code. In our o­pi­ni­on, the e­vi­den­ce we ha­ve ob­tai­ned is suf­fi­ci­ent and ap­pro­pri­ate to pro­vi­de a ba­sis for our qua­li­fi­ed con­clu­si­on.
													
													 
												
											
												
											</g:DescriptionOfQualificationsOfAuditedFinancialStatements>
   <g:TypeOfBasisForModifiedOpinionOnAuditedFinancialStatements contextRef="c40"
                                                                id="ParaIndex_3174_CellNumber_K3.E43_CellInstance_0"
                                                                xml:lang="en">Grundlag for konklusion med forbehold</g:TypeOfBasisForModifiedOpinionOnAuditedFinancialStatements>
   <g:SupplementaryInformationOnAudit contextRef="c40"
                                      id="SectionStart_3350_SectionEnd_3367_SectionUID_1566918545_ParaIndex_3352">Emphasis of matters related to the audit
												
											
												
											With effect for the current financial year, the company has transitioned from extended review to audit in accordance with international standards. The comparative figures have not been audited in accordance with international standards, but have been audited under the assurance standard for small enterprises (extended review).
													
													 
												
											
												
											</g:SupplementaryInformationOnAudit>
   <g:StatementOfExecutiveAndSupervisoryBoardsResponsibilityForFinancialStatements contextRef="c40"
                                                                                   id="SectionStart_3386_SectionEnd_3412_SectionUID_1566918546_ParaIndex_3388">Ma­na­ge­ment's Re­spon­si­bi­li­ti­es for the Fi­nan­ci­al Sta­te­ments
												
											
												
											Management is responsible for the preparation of Fi­nan­ci­al Sta­te­ments that give a true and fair view in accordance with the Da­nish Fi­nan­ci­al State­ments Act and for such Internal control as Ma­na­ge­ment determines is necessary to enable the preparation of Fi­nan­ci­al Sta­te­ments that are free from material misstatement, whether due to fraud or error.
													
													 
												
											
												
											In preparing the Fi­nan­ci­al Sta­te­ments, Ma­na­ge­ment is responsible for assessing the Com­pa­ny's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting in preparing the Fi­nan­ci­al Sta­te­ments unless Management either intends to liquidate the Com­pa­ny or to cease operations, or has no realistic alternative but to do so.
													
													 
												
											
												
											</g:StatementOfExecutiveAndSupervisoryBoardsResponsibilityForFinancialStatements>
   <g:StatementOfAuditorsResponsibilityForAuditAndAuditPerformed contextRef="c40"
                                                                 id="SectionStart_3440_SectionEnd_3655_SectionUID_1566918548_ParaIndex_3442">Our objectives are to obtain reasonable assurance about whether the Fi­nan­ci­al Sta­te­ments as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs and the additional requirements applicable in Denmark will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these Fi­nan­ci­al Sta­te­ments.
													
													 
												
											
												
											As part of an audit conducted in accordance with ISAs and the additional requirements applicable in Denmark, we exercise professional judgment and maintain professional skepticism throughout the audit. We also:
													
													 
												
											
												
											Identify and assess the risks of material misstatement of the Fi­nan­ci­al Sta­te­ments, whether due to fraud or error, design and perform audit procedures responsive to those risks, and obtain audit evidence that is sufficient and appropriate to provide a basis for our opinion. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control.
													
													 
												
											
												
											Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Com­pa­ny's internal control.
													
													 
												
											
												
											Evaluate the appropriateness of accounting policies used and the reasonableness of accounting estimates and related disclosures made by Ma­na­ge­ment.
													
													 
												
											
												
											Conclude on the appropriateness of Ma­na­ge­ment’s use of the going concern basis of accounting in preparing the Fi­nan­ci­al Sta­te­ments and, based on the audit evidence obtained, whether a material uncertainty exists related to events or conditions that may cast significant doubt on the Com­pa­ny's ability to continue as a going concern. If we conclude that a material uncertainty exists, we are required to draw attention in our auditor’s report to the related disclosures in the Fi­nan­ci­al Sta­te­ments or, if such disclosures are inadequate, to modify our opinion. Our conclusions are based on the audit evidence obtained up to the date of our auditor’s report. However, future events or conditions may cause the Com­pa­ny to cease to continue as a going concern.
													
													 
												
											
												
											Evaluate the overall presentation, structure and contents of the Fi­nan­ci­al Sta­te­ments, including the disclosures, and whether the Fi­nan­ci­al Sta­te­ments represent the underlying transactions and events in a manner that gives a true and fair view.
													
													 
												
											
												
											We communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit and significant audit findings, including any significant deficiencies in internal control that we identify during our audit.
													
													 
												
											
												
											</g:StatementOfAuditorsResponsibilityForAuditAndAuditPerformed>
   <g:StatementOnManagementsReviewAuditorsReportOnAuditedFinancialStatements contextRef="c40"
                                                                             id="SectionStart_3656_SectionEnd_3738_SectionUID_1566918558_ParaIndex_3658">Statement on Management Commentary
												
											
												
											Management is responsible for Ma­na­ge­ment Com­men­ta­ry.
													
													 
												
											
												
											Our opinion on the Fi­nan­ci­al Sta­te­ments does not cover Ma­na­ge­ment Com­men­ta­ry, and we do not express any form of assurance conclusion thereon.
													
													 
												
											
												
											In connection with our audit of the Fi­nan­ci­al Sta­te­ments, our responsibility is to read Ma­na­ge­ment Com­men­ta­ry and, in doing so, consider whether Ma­na­ge­ment Com­men­ta­ry is materially inconsistent with the Fi­nan­ci­al Sta­te­ments or our knowledge obtained during the audit, or otherwise appears to be materially misstated.
													
													 
												
											
												
											Moreover, it is our responsibility to consider whether Ma­na­ge­ment Com­men­ta­ry provides the information required under the Danish Financial Statements Act.
													
													 
												
											
												
											Based on the work we have performed, we conclude that Ma­na­ge­ment Com­men­ta­ry is in accordance with the Fi­nan­ci­al Sta­te­ments and has been prepared in accordance with the requirements of the Danish Financial Statements Act. We did not identify any material misstatement of Ma­na­ge­ment Com­men­ta­ry.
													
													 
												
											
												
											</g:StatementOnManagementsReviewAuditorsReportOnAuditedFinancialStatements>
   <g:SignatureOfAuditorsPlace contextRef="c40"
                               id="ParaIndex_6473_CellNumber_BY1V_CellInstance_0"
                               xml:lang="en">Vejle</g:SignatureOfAuditorsPlace>
   <g:SignatureOfAuditorsDate contextRef="c40">2026-04-21</g:SignatureOfAuditorsDate>
   <d:NameOfAuditFirm contextRef="c321"
                      id="ParaIndex_6488_CellNumber_K1.A4_CellInstance_0"
                      xml:lang="en">BDO Statsautoriseret Revisionspartnerselskab</d:NameOfAuditFirm>
   <d:IdentificationNumberCvrOfAuditFirm contextRef="c321"
                                         id="ParaIndex_6490_CellNumber_K1.B4_CellInstance_0"
                                         xml:lang="en">45719375</d:IdentificationNumberCvrOfAuditFirm>
   <d:NameAndSurnameOfAuditor contextRef="c321"
                              id="ParaIndex_6519_CellNumber_RNAVN1_CellInstance_0"
                              xml:lang="en">Lasse Bjerregaard Pedersen</d:NameAndSurnameOfAuditor>
   <d:TypeOfAuditorAssistance contextRef="c40"
                              id="ParaIndex_6520_CellNumber_K1.B10_CellInstance_0"
                              xml:lang="en">Den uafhængige revisors erklæring</d:TypeOfAuditorAssistance>
   <d:DescriptionOfAuditor contextRef="c321"
                           id="ParaIndex_6524_CellNumber_RTITEL1_CellInstance_0"
                           xml:lang="en">State Authorised Public Accountant</d:DescriptionOfAuditor>
   <d:IdentificationNumberOfAuditor contextRef="c321"
                                    id="ParaIndex_6539_CellNumber_RMNENR1_CellInstance_0"
                                    xml:lang="en">mne47803</d:IdentificationNumberOfAuditor>
   <h:DescriptionOfPrimaryActivitiesOfEntity contextRef="c40"
                                             id="SectionStart_8205_SectionEnd_8266_SectionUID_1317804858_ParaIndex_8220">Principal activities
												
											The company's activities consist of producing pigs for breeding and multiplication.
													
													 
												
											</h:DescriptionOfPrimaryActivitiesOfEntity>
   <h:DescriptionOfAnyUnusualMattersAffectingRecognitionOrMeasurement contextRef="c40"
                                                                      id="SectionStart_8313_SectionEnd_8358_SectionUID_1318592880_ParaIndex_8325">Unusual matters
												
											In connection with the preparation of the 2025 Annual Report, the Company has identified a material prior period error relating to the measurement of other equity investments.
													
													 
												
											Reference is made to the section on the applied accounting policies, including the description of the impact on the annual report arising from the correction of material misstatements.
													
													 
												
											The Company’s biological assets and livestock were previously measured at fair value through income statement. The accounting policy is being changed so that these items are now recognized and measured at cost. The comparative figures for last year have been adjusted in accordance with the new practice. 
													
													
													Reference is made to the description under accounting policies, including the description of the impact on the annual report of the change in accounting policies and classification.
													
													 
												
											</h:DescriptionOfAnyUnusualMattersAffectingRecognitionOrMeasurement>
   <h:DescriptionOfSignificantEventsOccurringAfterEndOfReportingPeriod contextRef="c40"
                                                                       id="SectionStart_8497_SectionEnd_8549_SectionUID_1318593640_ParaIndex_8509">Significant events after the end of the financial year
												
											The company is expected to be merged during 2026 with the sister breeding companies under Danish Genetics Holding ApS as part of the group’s ongoing structural consolidation.
													
													 
												
											</h:DescriptionOfSignificantEventsOccurringAfterEndOfReportingPeriod>
   <c:GrossProfitLoss contextRef="c40" decimals="0" unitRef="u1">4497931</c:GrossProfitLoss>
   <c:GrossProfitLoss contextRef="c182" decimals="0" unitRef="u1">6195847</c:GrossProfitLoss>
   <c:EmployeeBenefitsExpense contextRef="c40" decimals="0" unitRef="u1">3795875</c:EmployeeBenefitsExpense>
   <c:EmployeeBenefitsExpense contextRef="c182" decimals="0" unitRef="u1">4155830</c:EmployeeBenefitsExpense>
   <c:DepreciationAmortisationExpenseAndImpairmentLossesOfPropertyPlantAndEquipmentAndIntangibleAssetsRecognisedInProfitOrLoss contextRef="c40" decimals="0" unitRef="u1">88112</c:DepreciationAmortisationExpenseAndImpairmentLossesOfPropertyPlantAndEquipmentAndIntangibleAssetsRecognisedInProfitOrLoss>
   <c:DepreciationAmortisationExpenseAndImpairmentLossesOfPropertyPlantAndEquipmentAndIntangibleAssetsRecognisedInProfitOrLoss contextRef="c182" decimals="0" unitRef="u1">57532</c:DepreciationAmortisationExpenseAndImpairmentLossesOfPropertyPlantAndEquipmentAndIntangibleAssetsRecognisedInProfitOrLoss>
   <c:OtherOperatingExpenses contextRef="c40" decimals="0" unitRef="u1">0</c:OtherOperatingExpenses>
   <c:OtherOperatingExpenses contextRef="c182" decimals="0" unitRef="u1">37301</c:OtherOperatingExpenses>
   <c:ProfitLossFromOrdinaryOperatingActivities contextRef="c40" decimals="0" unitRef="u1">613944</c:ProfitLossFromOrdinaryOperatingActivities>
   <c:ProfitLossFromOrdinaryOperatingActivities contextRef="c182" decimals="0" unitRef="u1">1945184</c:ProfitLossFromOrdinaryOperatingActivities>
   <c:IncomeFromInvestmentsInGroupEnterprisesAndAssociates contextRef="c40" decimals="0" unitRef="u1">1945115</c:IncomeFromInvestmentsInGroupEnterprisesAndAssociates>
   <c:IncomeFromInvestmentsInGroupEnterprisesAndAssociates contextRef="c182" decimals="0" unitRef="u1">0</c:IncomeFromInvestmentsInGroupEnterprisesAndAssociates>
   <c:OtherFinanceIncome contextRef="c40" decimals="0" unitRef="u1">63502</c:OtherFinanceIncome>
   <c:OtherFinanceIncome contextRef="c182" decimals="0" unitRef="u1">30275</c:OtherFinanceIncome>
   <c:OtherFinanceExpenses contextRef="c40" decimals="0" unitRef="u1">432050</c:OtherFinanceExpenses>
   <c:OtherFinanceExpenses contextRef="c182" decimals="0" unitRef="u1">1188351</c:OtherFinanceExpenses>
   <c:ProfitLossFromOrdinaryActivitiesBeforeTax contextRef="c40" decimals="0" unitRef="u1">2190511</c:ProfitLossFromOrdinaryActivitiesBeforeTax>
   <c:ProfitLossFromOrdinaryActivitiesBeforeTax contextRef="c182" decimals="0" unitRef="u1">787108</c:ProfitLossFromOrdinaryActivitiesBeforeTax>
   <c:TaxExpense contextRef="c40" decimals="0" unitRef="u1">431587</c:TaxExpense>
   <c:TaxExpense contextRef="c182" decimals="0" unitRef="u1">291091</c:TaxExpense>
   <c:ProfitLoss contextRef="c40" decimals="0" unitRef="u1">1758924</c:ProfitLoss>
   <c:ProfitLoss contextRef="c182" decimals="0" unitRef="u1">496017</c:ProfitLoss>
   <c:TransferredToFromRetainedEarnings contextRef="c40" decimals="0" unitRef="u1">1758924</c:TransferredToFromRetainedEarnings>
   <c:TransferredToFromRetainedEarnings contextRef="c182" decimals="0" unitRef="u1">496017</c:TransferredToFromRetainedEarnings>
   <c:ProfitLoss contextRef="c40" decimals="0" unitRef="u1">1758924</c:ProfitLoss>
   <c:ProfitLoss contextRef="c182" decimals="0" unitRef="u1">496017</c:ProfitLoss>
   <c:AcquiredIntangibleAssets contextRef="c178" decimals="0" unitRef="u1">0</c:AcquiredIntangibleAssets>
   <c:AcquiredIntangibleAssets contextRef="c179" decimals="0" unitRef="u1">4578400</c:AcquiredIntangibleAssets>
   <c:Goodwill contextRef="c178" decimals="0" unitRef="u1">0</c:Goodwill>
   <c:Goodwill contextRef="c179" decimals="0" unitRef="u1">25000</c:Goodwill>
   <c:IntangibleAssets contextRef="c178" decimals="0" unitRef="u1">0</c:IntangibleAssets>
   <c:IntangibleAssets contextRef="c179" decimals="0" unitRef="u1">4603400</c:IntangibleAssets>
   <c:PlantAndMachinery contextRef="c178" decimals="0" unitRef="u1">166522</c:PlantAndMachinery>
   <c:PlantAndMachinery contextRef="c179" decimals="0" unitRef="u1">209968</c:PlantAndMachinery>
   <c:BiologicalAssets contextRef="c178" decimals="0" unitRef="u1">836037</c:BiologicalAssets>
   <c:BiologicalAssets contextRef="c179" decimals="0" unitRef="u1">957969</c:BiologicalAssets>
   <c:PropertyPlantAndEquipment contextRef="c178" decimals="0" unitRef="u1">1002559</c:PropertyPlantAndEquipment>
   <c:PropertyPlantAndEquipment contextRef="c179" decimals="0" unitRef="u1">1167937</c:PropertyPlantAndEquipment>
   <c:LongtermParticipatingInterests contextRef="c178" decimals="0" unitRef="u1">223336</c:LongtermParticipatingInterests>
   <c:LongtermParticipatingInterests contextRef="c179" decimals="0" unitRef="u1">0</c:LongtermParticipatingInterests>
   <c:DepositsLongtermInvestmentsAndReceivables contextRef="c178" decimals="0" unitRef="u1">32000</c:DepositsLongtermInvestmentsAndReceivables>
   <c:DepositsLongtermInvestmentsAndReceivables contextRef="c179" decimals="0" unitRef="u1">32000</c:DepositsLongtermInvestmentsAndReceivables>
   <c:LongtermInvestmentsAndReceivables contextRef="c178" decimals="0" unitRef="u1">255336</c:LongtermInvestmentsAndReceivables>
   <c:LongtermInvestmentsAndReceivables contextRef="c179" decimals="0" unitRef="u1">32000</c:LongtermInvestmentsAndReceivables>
   <c:NoncurrentAssets contextRef="c178" decimals="0" unitRef="u1">1257895</c:NoncurrentAssets>
   <c:NoncurrentAssets contextRef="c179" decimals="0" unitRef="u1">5803337</c:NoncurrentAssets>
   <c:RawMaterialsAndConsumables contextRef="c178" decimals="0" unitRef="u1">167234</c:RawMaterialsAndConsumables>
   <c:RawMaterialsAndConsumables contextRef="c179" decimals="0" unitRef="u1">1710080</c:RawMaterialsAndConsumables>
   <c:WorkInProgress contextRef="c178" decimals="0" unitRef="u1">3559307</c:WorkInProgress>
   <c:WorkInProgress contextRef="c179" decimals="0" unitRef="u1">3524624</c:WorkInProgress>
   <c:Inventories contextRef="c178" decimals="0" unitRef="u1">3726541</c:Inventories>
   <c:Inventories contextRef="c179" decimals="0" unitRef="u1">5234704</c:Inventories>
   <c:ShorttermTradeReceivables contextRef="c178" decimals="0" unitRef="u1">240175</c:ShorttermTradeReceivables>
   <c:ShorttermTradeReceivables contextRef="c179" decimals="0" unitRef="u1">803750</c:ShorttermTradeReceivables>
   <c:ShorttermReceivablesFromGroupEnterprises contextRef="c178" decimals="0" unitRef="u1">10720099</c:ShorttermReceivablesFromGroupEnterprises>
   <c:ShorttermReceivablesFromGroupEnterprises contextRef="c179" decimals="0" unitRef="u1">0</c:ShorttermReceivablesFromGroupEnterprises>
   <c:CurrentDeferredTaxAssets contextRef="c178" decimals="0" unitRef="u1">821141</c:CurrentDeferredTaxAssets>
   <c:CurrentDeferredTaxAssets contextRef="c179" decimals="0" unitRef="u1">1251900</c:CurrentDeferredTaxAssets>
   <c:OtherShorttermReceivables contextRef="c178" decimals="0" unitRef="u1">0</c:OtherShorttermReceivables>
   <c:OtherShorttermReceivables contextRef="c179" decimals="0" unitRef="u1">40547</c:OtherShorttermReceivables>
   <c:ShorttermTaxReceivables contextRef="c178" decimals="0" unitRef="u1">0</c:ShorttermTaxReceivables>
   <c:ShorttermTaxReceivables contextRef="c179" decimals="0" unitRef="u1">840</c:ShorttermTaxReceivables>
   <c:DeferredIncomeAssets contextRef="c178" decimals="0" unitRef="u1">154737</c:DeferredIncomeAssets>
   <c:DeferredIncomeAssets contextRef="c179" decimals="0" unitRef="u1">15726</c:DeferredIncomeAssets>
   <c:ShorttermReceivables contextRef="c178" decimals="0" unitRef="u1">11936152</c:ShorttermReceivables>
   <c:ShorttermReceivables contextRef="c179" decimals="0" unitRef="u1">2112763</c:ShorttermReceivables>
   <c:ShorttermInvestmentsInGroupEnterprises contextRef="c178" decimals="0" unitRef="u1">0</c:ShorttermInvestmentsInGroupEnterprises>
   <c:ShorttermInvestmentsInGroupEnterprises contextRef="c179" decimals="0" unitRef="u1">263221</c:ShorttermInvestmentsInGroupEnterprises>
   <c:ShorttermInvestments contextRef="c178" decimals="0" unitRef="u1">0</c:ShorttermInvestments>
   <c:ShorttermInvestments contextRef="c179" decimals="0" unitRef="u1">263221</c:ShorttermInvestments>
   <c:CashAndCashEquivalents contextRef="c178" decimals="0" unitRef="u1">792059</c:CashAndCashEquivalents>
   <c:CashAndCashEquivalents contextRef="c179" decimals="0" unitRef="u1">0</c:CashAndCashEquivalents>
   <c:CurrentAssets contextRef="c178" decimals="0" unitRef="u1">16454752</c:CurrentAssets>
   <c:CurrentAssets contextRef="c179" decimals="0" unitRef="u1">7610688</c:CurrentAssets>
   <c:Assets contextRef="c178" decimals="0" unitRef="u1">17712647</c:Assets>
   <c:Assets contextRef="c179" decimals="0" unitRef="u1">13414025</c:Assets>
   <c:ContributedCapital contextRef="c178" decimals="0" unitRef="u1">40000</c:ContributedCapital>
   <c:ContributedCapital contextRef="c179" decimals="0" unitRef="u1">40000</c:ContributedCapital>
   <c:RetainedEarnings contextRef="c178" decimals="0" unitRef="u1">14201161</c:RetainedEarnings>
   <c:RetainedEarnings contextRef="c179" decimals="0" unitRef="u1">-5278244</c:RetainedEarnings>
   <c:Equity contextRef="c178" decimals="0" unitRef="u1">14241161</c:Equity>
   <c:Equity contextRef="c179" decimals="0" unitRef="u1">-5238244</c:Equity>
   <c:LongtermPayablesToGroupEnterprises contextRef="c178" decimals="0" unitRef="u1">0</c:LongtermPayablesToGroupEnterprises>
   <c:LongtermPayablesToGroupEnterprises contextRef="c179" decimals="0" unitRef="u1">11146507</c:LongtermPayablesToGroupEnterprises>
   <c:LongtermLiabilitiesOtherThanProvisions contextRef="c178" decimals="0" unitRef="u1">0</c:LongtermLiabilitiesOtherThanProvisions>
   <c:LongtermLiabilitiesOtherThanProvisions contextRef="c179" decimals="0" unitRef="u1">11146507</c:LongtermLiabilitiesOtherThanProvisions>
   <c:ShorttermMortgageDebt contextRef="c178" decimals="0" unitRef="u1">0</c:ShorttermMortgageDebt>
   <c:ShorttermMortgageDebt contextRef="c179" decimals="0" unitRef="u1">2123356</c:ShorttermMortgageDebt>
   <c:ShorttermDebtToBanks contextRef="c178" decimals="0" unitRef="u1">0</c:ShorttermDebtToBanks>
   <c:ShorttermDebtToBanks contextRef="c179" decimals="0" unitRef="u1">4223451</c:ShorttermDebtToBanks>
   <c:ShorttermTradePayables contextRef="c178" decimals="0" unitRef="u1">1947080</c:ShorttermTradePayables>
   <c:ShorttermTradePayables contextRef="c179" decimals="0" unitRef="u1">609230</c:ShorttermTradePayables>
   <c:ShorttermPayablesToGroupEnterprises contextRef="c178" decimals="0" unitRef="u1">0</c:ShorttermPayablesToGroupEnterprises>
   <c:ShorttermPayablesToGroupEnterprises contextRef="c179" decimals="0" unitRef="u1">300621</c:ShorttermPayablesToGroupEnterprises>
   <c:ShorttermLiabilitiesOtherThanProvisions contextRef="c178" decimals="0" unitRef="u1">3471486</c:ShorttermLiabilitiesOtherThanProvisions>
   <c:ShorttermLiabilitiesOtherThanProvisions contextRef="c179" decimals="0" unitRef="u1">7505762</c:ShorttermLiabilitiesOtherThanProvisions>
   <c:LiabilitiesOtherThanProvisions contextRef="c178" decimals="0" unitRef="u1">3471486</c:LiabilitiesOtherThanProvisions>
   <c:LiabilitiesOtherThanProvisions contextRef="c179" decimals="0" unitRef="u1">18652269</c:LiabilitiesOtherThanProvisions>
   <c:LiabilitiesAndEquity contextRef="c178" decimals="0" unitRef="u1">17712647</c:LiabilitiesAndEquity>
   <c:LiabilitiesAndEquity contextRef="c179" decimals="0" unitRef="u1">13414025</c:LiabilitiesAndEquity>
   <c:DisclosureOfEquity contextRef="c40"
                         id="SectionStart_31969_SectionEnd_42907_SectionUID_1600426133_ParaIndex_31969">DKKSha­re ca­pi­talRetained earningsTotal
												
											
												
											Equity at 1 January 202540.0001.848.9801.888.980Change of equity due to correction of errors-623.504-623.504Change of equity due to change of policy-6.503.720-6.503.720Adjusted equity at 1 January 202540.000-5.278.244-5.238.244
												
											
												
											
												
											
												
											Proposed profit allocation
												
											1.758.9241.758.924Contribution from Group
												
											17.720.48117.720.481
												
											
												
											
												
											
												
											Equity at 31 December 202540.00014.201.16114.241.161
												
											
												
											
												
											
												
											
												
											
												
											
												
											
												
											
												
											
								
							</c:DisclosureOfEquity>
   <c:Equity contextRef="c188" decimals="0" unitRef="u1">40000</c:Equity>
   <c:Equity contextRef="c209" decimals="0" unitRef="u1">1848980</c:Equity>
   <c:IncreaseDecreaseOfEquityThroughCorrectionsOfErrors contextRef="c208" decimals="0" unitRef="u1">-623504</c:IncreaseDecreaseOfEquityThroughCorrectionsOfErrors>
   <c:IncreaseDecreaseOfEquityThroughChangesInAccountingPolicies contextRef="c208" decimals="0" unitRef="u1">-6503720</c:IncreaseDecreaseOfEquityThroughChangesInAccountingPolicies>
   <c:ProfitLoss contextRef="c208" decimals="0" unitRef="u1">1758924</c:ProfitLoss>
   <c:ContributionFromGroup contextRef="c208" decimals="0" unitRef="u1">17720481</c:ContributionFromGroup>
   <c:Equity contextRef="c189" decimals="0" unitRef="u1">40000</c:Equity>
   <c:Equity contextRef="c210" decimals="0" unitRef="u1">14201161</c:Equity>
   <c:DisclosureOfEmployeeBenefitsExpense contextRef="c40"
                                          id="SectionStart_77122_SectionEnd_86030_SectionUID_1312986540_ParaIndex_77123">
								
							1 | Staff costs
												
											
												
											
												
											Ave­ra­ge num­ber of full ti­me em­ploy­ees1012
												
											
												
											
												
											
												
											
												
											Wages and salaries 3.436.7443.581.993
												
											Pensions 252.110246.515
												
											Social security costs 93.290168.620
												
											Other staff costs 13.731158.702
												
											
												
											
												
											
												
											
												
											
												
											3.795.8754.155.830
												
											
												
											
												
											</c:DisclosureOfEmployeeBenefitsExpense>
   <c:AverageNumberOfEmployees contextRef="c40" decimals="0" unitRef="u0">10</c:AverageNumberOfEmployees>
   <c:AverageNumberOfEmployees contextRef="c182" decimals="0" unitRef="u0">12</c:AverageNumberOfEmployees>
   <c:WagesAndSalaries contextRef="c40" decimals="0" unitRef="u1">3436744</c:WagesAndSalaries>
   <c:WagesAndSalaries contextRef="c182" decimals="0" unitRef="u1">3581993</c:WagesAndSalaries>
   <c:PostemploymentBenefitExpense contextRef="c40" decimals="0" unitRef="u1">252110</c:PostemploymentBenefitExpense>
   <c:PostemploymentBenefitExpense contextRef="c182" decimals="0" unitRef="u1">246515</c:PostemploymentBenefitExpense>
   <c:SocialSecurityContributions contextRef="c40" decimals="0" unitRef="u1">93290</c:SocialSecurityContributions>
   <c:SocialSecurityContributions contextRef="c182" decimals="0" unitRef="u1">168620</c:SocialSecurityContributions>
   <c:OtherEmployeeExpense contextRef="c40" decimals="0" unitRef="u1">13731</c:OtherEmployeeExpense>
   <c:OtherEmployeeExpense contextRef="c182" decimals="0" unitRef="u1">158702</c:OtherEmployeeExpense>
   <c:EmployeeBenefitsExpense contextRef="c40" decimals="0" unitRef="u1">3795875</c:EmployeeBenefitsExpense>
   <c:EmployeeBenefitsExpense contextRef="c182" decimals="0" unitRef="u1">4155830</c:EmployeeBenefitsExpense>
   <c:DisclosureOfOtherFinanceIncome contextRef="c40"
                                     id="SectionStart_101160_SectionEnd_102543_SectionUID_1313574840_ParaIndex_101277">2 | Other financial income
												
											
												
											
												
											
												
											Interest income from group enterprises 9.1970
												
											Other interest income 54.30530.275
												
											
												
											
												
											
												
											
												
											
												
											
												
											63.50230.275
												
											
												
											
												
											</c:DisclosureOfOtherFinanceIncome>
   <c:InterestIncomeFromGroupEnterprises contextRef="c40" decimals="0" unitRef="u1">9197</c:InterestIncomeFromGroupEnterprises>
   <c:InterestIncomeFromGroupEnterprises contextRef="c182" decimals="0" unitRef="u1">0</c:InterestIncomeFromGroupEnterprises>
   <c:OtherInterestIncome contextRef="c40" decimals="0" unitRef="u1">54305</c:OtherInterestIncome>
   <c:OtherInterestIncome contextRef="c182" decimals="0" unitRef="u1">30275</c:OtherInterestIncome>
   <c:OtherFinanceIncome contextRef="c40" decimals="0" unitRef="u1">63502</c:OtherFinanceIncome>
   <c:OtherFinanceIncome contextRef="c182" decimals="0" unitRef="u1">30275</c:OtherFinanceIncome>
   <c:DisclosureOfOtherFinanceExpenses contextRef="c40"
                                       id="SectionStart_102544_SectionEnd_103927_SectionUID_1313587010_ParaIndex_102661">3 | Other financial expenses
												
											
												
											
												
											
												
											Interest expenses to group enterprises 0563.576
												
											Other interest expenses 432.050624.775
												
											
												
											
												
											
												
											
												
											
												
											
												
											432.0501.188.351
												
											
												
											
												
											</c:DisclosureOfOtherFinanceExpenses>
   <c:InterestExpenseAssignedToGroupEnterprises contextRef="c40" decimals="0" unitRef="u1">0</c:InterestExpenseAssignedToGroupEnterprises>
   <c:InterestExpenseAssignedToGroupEnterprises contextRef="c182" decimals="0" unitRef="u1">563576</c:InterestExpenseAssignedToGroupEnterprises>
   <c:OtherInterestExpenses contextRef="c40" decimals="0" unitRef="u1">432050</c:OtherInterestExpenses>
   <c:OtherInterestExpenses contextRef="c182" decimals="0" unitRef="u1">624775</c:OtherInterestExpenses>
   <c:OtherFinanceExpenses contextRef="c40" decimals="0" unitRef="u1">432050</c:OtherFinanceExpenses>
   <c:OtherFinanceExpenses contextRef="c182" decimals="0" unitRef="u1">1188351</c:OtherFinanceExpenses>
   <c:AdjustmentsForCurrentTaxOfPriorPeriod contextRef="c40" decimals="0" unitRef="u1">830</c:AdjustmentsForCurrentTaxOfPriorPeriod>
   <c:AdjustmentsForCurrentTaxOfPriorPeriod contextRef="c182" decimals="0" unitRef="u1">0</c:AdjustmentsForCurrentTaxOfPriorPeriod>
   <c:AdjustmentsForDeferredTax contextRef="c40" decimals="0" unitRef="u1">430757</c:AdjustmentsForDeferredTax>
   <c:AdjustmentsForDeferredTax contextRef="c182" decimals="0" unitRef="u1">291091</c:AdjustmentsForDeferredTax>
   <c:DisclosureOfIntangibleAssets contextRef="c40"
                                   id="SectionStart_106038_SectionEnd_115929_SectionUID_1455278332_ParaIndex_106400">5 | Intangible assets
												
											
												
											
												
											
												
											
												
											
												
											
												
											DKKAcquired concessions, patents, licences, trademarks and similar rightsGoodwill
												
											
												
											
												
											
												
											
												
											Cost at 1 January 2025 4.720.00050.000
												
											Disposals -4.720.0000
												
											Cost at 31 December 2025 050.000
												
											 
												
											
												
											
												
											Amortisation at 1 January 2025 141.60025.000
												
											Reversal of amortisation of assets disposed of  -161.2670
												
											Impairment losses 016.666
												
											Amortisation for the year 19.6678.334
												
											Amortisation at 31 December 2025 050.000
												
											
												
											
												
											
												
											
												
											Carrying amount at 31 December 202500
												
											
												
											
												
											</c:DisclosureOfIntangibleAssets>
   <c:IntangibleAssetsGross contextRef="c324" decimals="0" unitRef="u1">4720000</c:IntangibleAssetsGross>
   <c:IntangibleAssetsGross contextRef="c348" decimals="0" unitRef="u1">50000</c:IntangibleAssetsGross>
   <c:DisposalsOfIntangibleAssets contextRef="c323" decimals="0" unitRef="u1">4720000</c:DisposalsOfIntangibleAssets>
   <c:DisposalsOfIntangibleAssets contextRef="c347" decimals="0" unitRef="u1">0</c:DisposalsOfIntangibleAssets>
   <c:IntangibleAssetsGross contextRef="c326" decimals="0" unitRef="u1">0</c:IntangibleAssetsGross>
   <c:IntangibleAssetsGross contextRef="c350" decimals="0" unitRef="u1">50000</c:IntangibleAssetsGross>
   <c:AccumulatedImpairmentLossesAndAmortisationOfIntangibleAssets contextRef="c324" decimals="0" unitRef="u1">141600</c:AccumulatedImpairmentLossesAndAmortisationOfIntangibleAssets>
   <c:AccumulatedImpairmentLossesAndAmortisationOfIntangibleAssets contextRef="c348" decimals="0" unitRef="u1">25000</c:AccumulatedImpairmentLossesAndAmortisationOfIntangibleAssets>
   <c:ReversalsOfImpairmentLossesAndAmortisationOfDisposedIntangibleAssets contextRef="c323" decimals="0" unitRef="u1">161267</c:ReversalsOfImpairmentLossesAndAmortisationOfDisposedIntangibleAssets>
   <c:ReversalsOfImpairmentLossesAndAmortisationOfDisposedIntangibleAssets contextRef="c347" decimals="0" unitRef="u1">0</c:ReversalsOfImpairmentLossesAndAmortisationOfDisposedIntangibleAssets>
   <c:ImpairmentLossesOfIntangibleAssets contextRef="c323" decimals="0" unitRef="u1">0</c:ImpairmentLossesOfIntangibleAssets>
   <c:ImpairmentLossesOfIntangibleAssets contextRef="c347" decimals="0" unitRef="u1">16666</c:ImpairmentLossesOfIntangibleAssets>
   <c:AmortisationOfIntangibleAssets contextRef="c323" decimals="0" unitRef="u1">19667</c:AmortisationOfIntangibleAssets>
   <c:AmortisationOfIntangibleAssets contextRef="c347" decimals="0" unitRef="u1">8334</c:AmortisationOfIntangibleAssets>
   <c:AccumulatedImpairmentLossesAndAmortisationOfIntangibleAssets contextRef="c326" decimals="0" unitRef="u1">0</c:AccumulatedImpairmentLossesAndAmortisationOfIntangibleAssets>
   <c:AccumulatedImpairmentLossesAndAmortisationOfIntangibleAssets contextRef="c350" decimals="0" unitRef="u1">50000</c:AccumulatedImpairmentLossesAndAmortisationOfIntangibleAssets>
   <c:IntangibleAssets contextRef="c326" decimals="0" unitRef="u1">0</c:IntangibleAssets>
   <c:IntangibleAssets contextRef="c350" decimals="0" unitRef="u1">0</c:IntangibleAssets>
   <c:DisclosureOfPropertyPlantAndEquipment contextRef="c40"
                                            id="SectionStart_115930_SectionEnd_124796_SectionUID_1314865473_ParaIndex_116324">6 | Property, plant and equipment
												
											
												
											
												
											
												
											
												
											
												
											
												
											DKKProduction plant and machineryBiological assets
												
											
												
											
												
											
												
											
												
											Cost at 1 January 2025 211.966957.969
												
											Additions 0557.358
												
											Disposals 0-679.290
												
											Cost at 31 December 2025 211.966836.037
												
											 
												
											
												
											
												
											Depreciation and impairment losses at 1 January 2025 1.9920
												
											Depreciation for the year 43.4520
												
											Depreciation and impairment losses at 31 December 2025 45.4440
												
											
												
											
												
											
												
											
												
											Carrying amount at 31 December 2025166.522836.037
												
											
												
											
												
											</c:DisclosureOfPropertyPlantAndEquipment>
   <c:PropertyPlantAndEquipmentGross contextRef="c545" decimals="0" unitRef="u1">211966</c:PropertyPlantAndEquipmentGross>
   <c:PropertyPlantAndEquipmentGross contextRef="c515" decimals="0" unitRef="u1">957969</c:PropertyPlantAndEquipmentGross>
   <c:AdditionsToPropertyPlantAndEquipment contextRef="c543" decimals="0" unitRef="u1">0</c:AdditionsToPropertyPlantAndEquipment>
   <c:AdditionsToPropertyPlantAndEquipment contextRef="c513" decimals="0" unitRef="u1">557358</c:AdditionsToPropertyPlantAndEquipment>
   <c:DisposalsOfPropertyPlantAndEquipment contextRef="c543" decimals="0" unitRef="u1">0</c:DisposalsOfPropertyPlantAndEquipment>
   <c:DisposalsOfPropertyPlantAndEquipment contextRef="c513" decimals="0" unitRef="u1">679290</c:DisposalsOfPropertyPlantAndEquipment>
   <c:PropertyPlantAndEquipmentGross contextRef="c547" decimals="0" unitRef="u1">211966</c:PropertyPlantAndEquipmentGross>
   <c:PropertyPlantAndEquipmentGross contextRef="c517" decimals="0" unitRef="u1">836037</c:PropertyPlantAndEquipmentGross>
   <c:AccumulatedImpairmentLossesAndDepreciationOfPropertyPlantAndEquipment contextRef="c545" decimals="0" unitRef="u1">1992</c:AccumulatedImpairmentLossesAndDepreciationOfPropertyPlantAndEquipment>
   <c:AccumulatedImpairmentLossesAndDepreciationOfPropertyPlantAndEquipment contextRef="c515" decimals="0" unitRef="u1">0</c:AccumulatedImpairmentLossesAndDepreciationOfPropertyPlantAndEquipment>
   <c:DepreciationOfPropertyPlantAndEquipment contextRef="c543" decimals="0" unitRef="u1">43452</c:DepreciationOfPropertyPlantAndEquipment>
   <c:DepreciationOfPropertyPlantAndEquipment contextRef="c513" decimals="0" unitRef="u1">0</c:DepreciationOfPropertyPlantAndEquipment>
   <c:AccumulatedImpairmentLossesAndDepreciationOfPropertyPlantAndEquipment contextRef="c547" decimals="0" unitRef="u1">45444</c:AccumulatedImpairmentLossesAndDepreciationOfPropertyPlantAndEquipment>
   <c:AccumulatedImpairmentLossesAndDepreciationOfPropertyPlantAndEquipment contextRef="c517" decimals="0" unitRef="u1">0</c:AccumulatedImpairmentLossesAndDepreciationOfPropertyPlantAndEquipment>
   <c:PropertyPlantAndEquipment contextRef="c547" decimals="0" unitRef="u1">166522</c:PropertyPlantAndEquipment>
   <c:PropertyPlantAndEquipment contextRef="c517" decimals="0" unitRef="u1">836037</c:PropertyPlantAndEquipment>
   <c:DisclosureOfInvestments contextRef="c40"
                              id="SectionStart_124797_SectionEnd_133521_SectionUID_1455630891_ParaIndex_125132">7 | Financial non-current assets
												
											
												
											
												
											
												
											
												
											
												
											
												
											DKKInvestments in equityRent deposit and other receivables
												
											
												
											
												
											
												
											
												
											
												
											Cost at 1 January 2025 223.33632.000
												
											Cost at 31 December 2025 223.33632.000
												
											 
												
											
												
											
												
											Carrying amount at 31 December 2025223.33632.000
												
											
												
											
												
											
												
											
												
											
												
											
												
											
												
											
												
											</c:DisclosureOfInvestments>
   <c:InvestmentsGross contextRef="c592" decimals="0" unitRef="u1">223336</c:InvestmentsGross>
   <c:InvestmentsGross contextRef="c602" decimals="0" unitRef="u1">32000</c:InvestmentsGross>
   <c:InvestmentsGross contextRef="c594" decimals="0" unitRef="u1">223336</c:InvestmentsGross>
   <c:InvestmentsGross contextRef="c604" decimals="0" unitRef="u1">32000</c:InvestmentsGross>
   <c:LongtermInvestmentsAndReceivables contextRef="c594" decimals="0" unitRef="u1">223336</c:LongtermInvestmentsAndReceivables>
   <c:LongtermInvestmentsAndReceivables contextRef="c604" decimals="0" unitRef="u1">32000</c:LongtermInvestmentsAndReceivables>
   <c:DisclosureOfLongtermLiabilities contextRef="c40"
                                      id="SectionStart_166593_SectionEnd_167595_SectionUID_1546857681_ParaIndex_166634">8 | Long-term liabilities
												
											
												
											
												
											
												
											31/12 2025RepaymentDebt outstanding31/12 2024DKKtotal liabilitiesnext yearafter 5 yearstotal liabilities
												
											
												
											
												
											
												
											
												
											Debt to mortgage credit institution 0002.123.356Bank debt 0002.337.495Payables to group enterprises 00011.146.507
												
											
												
											
												
											
												
											
												
											
												
											00015.607.358
												
											
												
											</c:DisclosureOfLongtermLiabilities>
   <c:LongtermLiabilitiesOtherThanProvisionsDueAfterFiveYearsAndMore contextRef="c178" decimals="0" unitRef="u1">0</c:LongtermLiabilitiesOtherThanProvisionsDueAfterFiveYearsAndMore>
   <c:DisclosureOfContingentLiabilities contextRef="c40"
                                        id="SectionStart_186894_SectionEnd_188065_SectionUID_1734090492_ParaIndex_187423">Joint liabilitiesThe Company is jointly and severally liable together with the Parent Company and the other group companies in the joint taxable group for tax on the group’s joint taxable income and for certain possible withholding taxes, such as dividend tax, etc.
												
											Tax payable on the Group’s joint taxable income is stated in the annual report of Hendrix Genetics Swine ApS, which serves as management Company for the joint taxation.
												
											
												
											
												
											
												
											
												
											2025
												
											
												
											
												
											DKK
												
											
												
											Other financial commitments
												
											
												
											The company has entered into a lease agreement with a non-cancellable period of 10 years.
												
											
												
											
												
											
												
											The total other financial commitments as of the balance sheet date amount to: 16.516.991
												
											
												
											
												
											
												
											
												
											</c:DisclosureOfContingentLiabilities>
   <c:InformationOnConsolidatedFinancialStatements contextRef="c40"
                                                   id="SectionStart_190086_SectionEnd_190172_SectionUID_1468306949_ParaIndex_190153">10 | Consolidated Financial Statements
												
											
												
											
												
											
												
											The Company is included in the consolidated financial statements of Hendrix Genetics Holding B.V.,
													
													Spoorstraat 69 5831 CK Boxmeer, Holland.
													
													 
												
											
												
											</c:InformationOnConsolidatedFinancialStatements>
   <c:InformationOnReportingClassOfEntity contextRef="c40"
                                          id="SectionStart_191015_SectionEnd_191155_SectionUID_1724747612_ParaIndex_191017">The Annual Report of Solvang Genetics ApS for 2025 has been presented in accor­dance with the pro­vi­sions of the Da­nish Fi­nan­ci­al State­ments Act for en­ter­pri­ses in re­por­ting class B and cer­tain pro­vi­si­ons ap­ply­ing to re­por­ting class C.
													
													 Regnskabsklasse B1truetrue</c:InformationOnReportingClassOfEntity>
   <c:ClassOfReportingEntity contextRef="c40">Regnskabsklasse B</c:ClassOfReportingEntity>
   <c:SelectedElementsFromReportingClassC contextRef="c40">true</c:SelectedElementsFromReportingClassC>
   <c:InformationOnChangesAndEffectsOfChangesOnRecognitionAndMeasurementBasisResultingFromChangesInAccountingEstimatesOrErrors contextRef="c40"
                                                                                                                               id="SectionStart_191156_SectionEnd_191344_SectionUID_1724747619_ParaIndex_191158">The Annual Report is prepared consistently with the accounting principles applied last year, except for the following changes.
													
													 
												
											
												
											Change in accounting policies and classification
												
											
												
											The accounting policies have been changed in the following areas:
													
													 
												
											
												
											The company has, during the financial year, changed its accounting policy for the measurement of biological assets. Biological assets, which were previously measured at fair value, are now measured at cost less accumulated depreciation and impairment.
												
											
												
											The company has, during the financial year, changed its accounting policy for the measurement of Livestock. Livestock, which were previously measured at fair value, are now measured at cost.
												
											
												
											The changes has been made as a result of a modification in group policy following the company’s entry into a new group.
												
											
												
											The change in accounting policy has been applied retrospectively, and comparative figures have been adjusted accordingly.
												
											
												
											
												
											
												
											
												
											The accumulated impact of the changes in practice, compared to the previous accounting policies, has affected the financial statements as follows:
													
													 
												
											
												
											The changes has been incorporated into the annual report and has resulted in the income statement item “gross loss” for the financial year 2024 has been increased by DKK 177 thousand. The accumulated effect of the above change in accounting policies results in an increase in profit for the year before tax of DKK 177 thousand. The tax impact of the change in accounting policies amounts to DKK 39 thousand, resulting in an increase in profit for the year after tax of DKK 138 thousand.
												
											
												
											Total assets have been reduced by DKK 8.338 thousand, relating to livestock.
												
											
												
											The overall change in accounting policy has impact the calculation of defered tax with an increase of DKK 1.834 thousand.
												
											
												
											Equity has been reduced by DKK 6.504 thousand.
												
											
												
											
												
											
												
											
												
											</c:InformationOnChangesAndEffectsOfChangesOnRecognitionAndMeasurementBasisResultingFromChangesInAccountingEstimatesOrErrors>
   <c:ExplanationOfChangeInRecognitionAndMeasurementBasisOfAssetsAndLiabilitiesAsResultOfErrors contextRef="c40"
                                                                                                id="SectionStart_191404_SectionEnd_191441_SectionUID_1450690105_ParaIndex_191422">Change resulting from material misstatement
												
											
												
											In connection with the preparation of the 2025 Annual Report, the Company has identified a material prior period error relating to the measurement of Other securities and equity interests. In the 2024 financial statements, these investments were incorrectly measured at equity value. In accordance with the Company’s accounting policies, such investments must be measured at cost.
														
														
														The error has been corrected in the annual report and has resulted in no changes to the income statement, taxes or profit for the year 2024. Furthermore, the balance sheet item “Other securities and equity interests” at 31 December 2024 has been reduced by DKK 624 thousand due to the correction relating to prior years. In total, the correction results in equity as at 31 December 2024 being reduced by DKK 624 thousand, including the reduction in opening equity for 2024.
														
														
														The correction has had no impact on the calculation of tax.
														
														
														The total effect of the material error has been recognised directly in equity under the item “Correction of errors”. The total impact on equity and total assets amounts to DKK 624 thousand.
														
														
														Furthermore, in connection with the preparation of the 2025 Annual Report, the Company has identified a material prior period error relating to the classification of breeding animals, which have to be classified as  Biological assets. In the financial statement, the Biological assets were incorrectly shown as inventory.
														
														
														The error has been corrected in the annual report and has resulted in an increase of Biological assets of DKK 958 thousand and decreased Livestock with DKK 958 thousand. 
														
														
														The classification error has no effect on the income statement, Profit of the year 2024, taxes, total assets nor equity. 
													
												
													
												</c:ExplanationOfChangeInRecognitionAndMeasurementBasisOfAssetsAndLiabilitiesAsResultOfErrors>
   <c:DescriptionOfEffectOfChangeInRecognitionAndMeasurementBasisOfAssetsAndLiabilitiesAsResultOfErrors contextRef="c40"
                                                                                                        id="SectionStart_191428_SectionEnd_191434_SectionUID_1450690106_ParaIndex_191430">In connection with the preparation of the 2025 Annual Report, the Company has identified a material prior period error relating to the measurement of Other securities and equity interests. In the 2024 financial statements, these investments were incorrectly measured at equity value. In accordance with the Company’s accounting policies, such investments must be measured at cost.
														
														
														The error has been corrected in the annual report and has resulted in no changes to the income statement, taxes or profit for the year 2024. Furthermore, the balance sheet item “Other securities and equity interests” at 31 December 2024 has been reduced by DKK 624 thousand due to the correction relating to prior years. In total, the correction results in equity as at 31 December 2024 being reduced by DKK 624 thousand, including the reduction in opening equity for 2024.
														
														
														The correction has had no impact on the calculation of tax.
														
														
														The total effect of the material error has been recognised directly in equity under the item “Correction of errors”. The total impact on equity and total assets amounts to DKK 624 thousand.
														
														
														Furthermore, in connection with the preparation of the 2025 Annual Report, the Company has identified a material prior period error relating to the classification of breeding animals, which have to be classified as  Biological assets. In the financial statement, the Biological assets were incorrectly shown as inventory.
														
														
														The error has been corrected in the annual report and has resulted in an increase of Biological assets of DKK 958 thousand and decreased Livestock with DKK 958 thousand. 
														
														
														The classification error has no effect on the income statement, Profit of the year 2024, taxes, total assets nor equity. 
													
												
													
												</c:DescriptionOfEffectOfChangeInRecognitionAndMeasurementBasisOfAssetsAndLiabilitiesAsResultOfErrors>
   <c:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfRevenue contextRef="c40"
                                                                    id="SectionStart_191954_SectionEnd_192028_SectionUID_1450690117_ParaIndex_191974">Net revenue
												
											
												
											Net revenue from the sale of merchandise and finished goods is recognised in the Income Statement if supply and risk transfer to purchaser has taken place before the end of the year and if the income can be measured reliably and is expected to be received.
													
													 
												
											
												
											Net revenue is recognised exclusive of VAT and less duties and discounts related to the sale.
													
													 
												
											
												
											</c:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfRevenue>
   <c:DescriptionOfRawMaterialsAndConsumablesUsed contextRef="c40"
                                                  id="SectionStart_192168_SectionEnd_192207_SectionUID_1711114111_ParaIndex_192188">Costs of raw materials and consumables
												
											
												
											Raw materials and consumables comprises the costs of raw materials and consumables used to reach the revenue for the year. Additionally, decrease or increase of inventories of raw materials and consumables for the year is included, as well as normal impairment of inventories of raw materials and consumables.
													
													 
												
											
												
											</c:DescriptionOfRawMaterialsAndConsumablesUsed>
   <c:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfOtherOperatingIncome contextRef="c40"
                                                                                 id="SectionStart_192354_SectionEnd_192399_SectionUID_1450690132_ParaIndex_192373">Other operating income
												
											
												
											Other operating income includes items of a secondary nature in relation to the enterprises' principal activities, including profit from sale of intangible assets and property, plant and equipment, operating loss and conflict compensations, as well as salary refunds. Compensations are recognised when the income is estimated to be realisable. 
													
													 
												
											
												
											</c:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfOtherOperatingIncome>
   <c:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfExternalExpenses contextRef="c40"
                                                                             id="SectionStart_192440_SectionEnd_192500_SectionUID_1450690123_ParaIndex_192460">Other external expenses
												
											Other external expenses include other production, sales, delivery and administrative costs, including costs of energy, marketing, premises, loss on bad debts,  lease expenses, etc
													
													 
												
											
												
											</c:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfExternalExpenses>
   <c:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfEmployeeBenefitExpense contextRef="c40"
                                                                                   id="SectionStart_192501_SectionEnd_192539_SectionUID_1450690136_ParaIndex_192520">Staff costs
												
											
												
											Staff costs comprise wages and salaries, including holiday pay and pensions, and other costs of social security etc., for the Com­pa­ny's employees.
													
													 
												
											
												
											</c:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfEmployeeBenefitExpense>
   <c:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfOtherOperatingExpenses contextRef="c40"
                                                                                   id="SectionStart_192540_SectionEnd_192585_SectionUID_1450690134_ParaIndex_192558">Other operating expenses
												
											
												
											Other operating expenses include items of a secondary nature in relation to the Group’s and the Company’s activities. Losses from sale of intangible assets and property, plant and equipment are also included.
													
													 
												
											
												
											</c:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfOtherOperatingExpenses>
   <c:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfIncomeAndExpensesFromInvestmentsInGroupEnterprisesAndAssociates contextRef="c40"
                                                                                                                            id="SectionStart_192632_SectionEnd_192697_SectionUID_1450690140_ParaIndex_192664">Income from investments in equities
												
											
												
											
												
											Dividend from e­qui­ti­es is recognised in the financial year in which the dividend is declared. In connection with transfers, potential profits are recognised when the economic rights related to the sold equity interests are transferred, however, at the earliest when the profit has been realised or is regarded as realisable. Moreover, realised losses other than impairments are included where identified.
													
													 
												
											
												
											</c:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfIncomeAndExpensesFromInvestmentsInGroupEnterprisesAndAssociates>
   <c:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfFinanceIncomeAndExpenses contextRef="c40"
                                                                                     id="SectionStart_192736_SectionEnd_192787_SectionUID_1450690142_ParaIndex_192754">Financial income and expenses
												
											
												
											
												
											Financial income and expenses include interest income and expenses, realised and unrealised gains and losses arising from securities, debt and transactions in foreign currencies , as well as charges and allowances under the tax-on-account scheme, etc. Financial income and expenses are recognised by the amounts that relate to the financial year. Interest income and expenses are calculated on amortised cost prices.
													
													 
												
											
												
											</c:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfFinanceIncomeAndExpenses>
   <c:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfTaxExpenses contextRef="c40"
                                                                        id="SectionStart_192826_SectionEnd_192870_SectionUID_1450690146_ParaIndex_192844">Tax
												
											
												
											
												
											The tax for the year, which consists of the current tax for the year and changes in deferred tax, is recognised in the Income Statement by the share that may be attributed to the profit for the year, and is recognised directly in equity by the share that may be attributed to entries directly to equity.
													
													 
												
											
												
											</c:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfTaxExpenses>
   <c:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfIntangibleAssets contextRef="c40"
                                                                             id="SectionStart_192962_SectionEnd_193050_SectionUID_1450690151_ParaIndex_192982">Intangible fixed assets
												
											
												
											
												
											Acquired goodwill is measured at cost less accumulated amortisation. Goodwill is amortised on a straight-line basis over the expected useful life which is estimated to 5 years. The period of amortisation is determined based on an assessment of the acquired Company’s position in the market and earnings profile, and the industry-specific conditions.
													
													 
												
											
												
											Patents and licences are measured at the lower of cost less accumulated amortisation and the recoverable amount. Patents are amortised over the remaining patent period and licences are amortised over the period of the agreement, however, no more than 8 years.
													
													 
												
											
												
											Profit or loss from sale of intangible fixed assets is calculated at the difference between the sales price and the carrying amount at the time of the sale. Profit and loss are recognised in the Income Statement under other operating income or other operating expenses. 
													
													 
												
											
												
											</c:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfIntangibleAssets>
   <c:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfPropertyPlantAndEquipment contextRef="c40"
                                                                                      id="SectionStart_193051_SectionEnd_193214_SectionUID_1450690153_ParaIndex_193069">Property, plant and equipment
												
											
												
											
												
											Production plant and machinery are measured at cost less accumulated depreciation and impairment losses.
													
													 
												
											
												
											The depreciation base is cost less estimated residual value after end of useful life.
													
													 
												
											
												
											The cost includes the acquisition price and costs incurred directly in connection with the acquisition until the time when the asset is ready to be used. 
													
													 
												
											
												
											Straight-line depreciation is provided on the basis of an assessment of the expected useful lives of the assets and their residual value:
													
													 
												
											
												
											
												
											
												
											Useful lifeResidual valueProduction plant and machinery
												
											3 years0 %Biological assets
												
											1-2 yearsSlaughter value
												
												Biological assets, which is consisting of livestock, are meassured at cost. Breeding animals are measured at
													
													cost less accumulated depreciation and impairment to reflect biological aging.
													
													
													Entry animals’ represent the value of a highly pregnant gilt/heifer. The value of entry animals is determined
													
													based on either the purchase price or the production costs incurred over the replacement period.
													
													 
												
											
												
											</c:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfPropertyPlantAndEquipment>
   <c:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfInvestments contextRef="c40"
                                                                        id="SectionStart_193274_SectionEnd_193488_SectionUID_1574337448_ParaIndex_193301">Financial non-current assets
												
											
												
											
												
											Investments in e­qui­ti­es are measured at cost. If the cost exceeds the net realisable value, this is written down to the lower value.
													
													 
												
											
												
											</c:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfInvestments>
   <c:DescriptionOfMethodsOfAmortisationOfNoncurrentAssets contextRef="c40"
                                                           id="SectionStart_193489_SectionEnd_193572_SectionUID_1450690162_ParaIndex_193511">Impairment of fixed assets
												
											
												
											
												
											The carrying amount of in­tan­gib­le fi­xed and pro­per­ty, plant and equip­ment to­get­her with fi­xed as­sets, which are not mea­su­red at fair va­lue,, are assessed annually for indications of impairment other than that reflected by amortisation and depreciation.
													
													 
												
											
												
											In the event of impairment indications, an impairment test is made for each asset or group of assets, respectively. If the recoverable amount is lower than the carrying amount, the asset is written down to the recoverable amount.
													
													 
												
											
												
											The recoverable amount is calculated at the higher of the capital value and the sales value less expected costs of a sale. The capital value is determined as the Company's share in the current value of the net cash flows which the subsidiary is expected to generate through its activities and from sale of assets after the end of their useful lives. A discount rate is used which reflects the risk-free market rate and the owners' minimum return on interest requirements for similar assets. The growth rate in the terminal period is determined in accordance with the standards within the industry.
													
													 
												
											
												
											</c:DescriptionOfMethodsOfAmortisationOfNoncurrentAssets>
   <c:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfInventories contextRef="c40"
                                                                        id="SectionStart_193573_SectionEnd_193646_SectionUID_1450690164_ParaIndex_193592">Inventories
												
											
												
											
												
											nventories are measured at cost using the FIFO-principle. If the net realisable amount is lower than cost, the
													
													inventories are written down to the lower amount.
													
													 
												
											
												
											The cost of livestock includes the cost of raw materials, consumables, direct payroll cost and other direct and other indirect production costs include indirect mate­rials and payroll and maintenance and depreci­ation of the machines, factory buildings and equipment used in the production process, the cost of factory administration and management and capitalised development costs relating to the products.
													
													 
												
											
												
											The net realisable value of inventories is stated at the expected sales price less direct completion costs and costs incurred to execute the sale and is determined with due regard to marketability, obsolescence and development in expected sales price of the inventories.
													
													 
												
											
												
											</c:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfInventories>
   <c:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfReceivables contextRef="c40"
                                                                        id="SectionStart_193647_SectionEnd_193719_SectionUID_1450690166_ParaIndex_193665">Receivables
												
											
												
											
												
											Receivables are measured at amortised cost which usually corresponds to nominal value. The value is written down to meet expected losses.
													
													 
												
											
												
											Write-off is performed to provide for losses when an objective indication has been assessed to have incurred that a receivable or a portfolio of receivables are impaired. If there is an objective indication that an individual receivable is impaired, the write-off is performed at individual level.
													
													 
												
											
												
											</c:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfReceivables>
   <c:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfDeferredIncomeAssets contextRef="c40"
                                                                                 id="SectionStart_193786_SectionEnd_193830_SectionUID_1450690170_ParaIndex_193804">Accruals, assets
												
											
												
											
												
											Accruals recognised as assets include costs incur­red relating to the subsequent financial year.
													
													 
												
											
												
											</c:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfDeferredIncomeAssets>
   <c:DescriptionOfMethodsOfInvestmentsAsCurrentAssets contextRef="c40"
                                                       id="SectionStart_193831_SectionEnd_193875_SectionUID_1450690171_ParaIndex_193848">Securities and investments
												
											
												
											
												
											Securities and investments, recognised as current assets, comprise public quoted bonds, shares and other securities. Public quoted securities are measured at the market price. Non-quoted equity interests are measured at cost price. Other securities are measured at cost price in so far as an approximate sales value cannot be stated reliably.
													
													 
												
											
												
											</c:DescriptionOfMethodsOfInvestmentsAsCurrentAssets>
   <c:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfTaxPayablesAndDeferredTax contextRef="c40"
                                                                                      id="SectionStart_194083_SectionEnd_194176_SectionUID_1450690181_ParaIndex_194101">Tax payable and deferred tax
												
											
												
											
												
											Current tax liabilities and receivable current tax are recognised in the Balance Sheet as the calculated tax on the taxable income for the year, ad­justed for tax on the taxable income for previous years and taxes paid on account.
													
													 
												
											
												
											The Company is subject to joint taxation with Danish Group companies. The current corporation tax is distributed among the joint taxable companies in proportion to their taxable income and with full allocation and refund related to tax losses. The joint taxable companies are included in the tax-on-account scheme. Joint taxation contributions receivable and payable are recognised in the Balance Sheet under current assets and liabilities, respectively.
													
													 
												
											
												
											Deferred tax is measured on the temporary dif­ferences between the carrying amount and the tax value of assets and liabilities.
													
													 
												
											
												
											Deferred tax assets, including the tax value of tax loss carryforwards, are measured at the amount at which the asset is expected to be used within a reasonable number of years, either by setoff against tax on future earnings or by setoff against deferred tax liabilities within the same legal tax entity.
													
													 
												
											
												
											Deferred tax is measured on the basis of the tax rules and tax rates that under the legislation in force on the Balance Sheet date will be ap­pli­cable when the deferred tax is expected to crystallise as current tax. Any changes in the deferred tax resulting from changes in tax rates, are recognised in the income statement, except from items recognised directly in equity.
													
													 
												
											
												
											</c:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfTaxPayablesAndDeferredTax>
   <c:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfLiabilitiesOtherThanProvisions contextRef="c40"
                                                                                           id="SectionStart_194177_SectionEnd_194228_SectionUID_1450690184_ParaIndex_194195">Liabilities
												
											
												
											
												
											Financial liabilities are recognised at the time of borrowing by the amount of proceeds received less transaction costs. In subsequent periods, the financial liabilities are measured at amortised cost equal to the capitalised value when using the effective interest, the difference between the proceeds and the nominal value being recog­nised in the Income Statement over the loan period.
													
													 
												
											
												
											The amortised cost of current liabilities corresponds usually to the nominal value.
													
													 
												
											
												
											</c:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfLiabilitiesOtherThanProvisions>
   <c:DescriptionOfMethodsOfTranslationOfForeignCurrencies contextRef="c40"
                                                           id="SectionStart_194341_SectionEnd_194430_SectionUID_1450690188_ParaIndex_194359">Foreign currency translation
												
											
												
											
												
											Transactions in foreign currencies are translated at the rate of exchange on the transaction date. Exchange differences arising between the rate on the transaction date and the rate on the payment date are recognised in the Income Statement as a financial income or expense.
												
											
												
											
												
											Receivables, payables and other monetary items in foreign currencies that are not settled on the Balance Sheet date are translated at the exchange rate on the Balance Sheet date. The difference between the exchange rate on the Balance Sheet date and the exchange rate at the date when the receivables or payables come into existence recognised in the Income Statement as financial income or expenses.
												
											
												
											
												
											Fixed assets acquired in foreign currencies are translated at the rate of exchange on the transaction date.
													
													 
												
											
												
											</c:DescriptionOfMethodsOfTranslationOfForeignCurrencies>
</xbrli:xbrl>
